Accolade Stock News

NEW YORK & TORONTO--(BUSINESS WIRE)-- #Advertising--Klick Health is capping off The One Club's Creative Week tonight with a groundbreaking win, becoming the first health agency in The One Show's 52-year history to ever be named an Agency of the Year. As The One Show's 2025 Independent Agency of the Year and the recipient of 83 campaign accolades over the course of the week, Klick is helping sig...

Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Business Growth Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Business Growth

Pernod Ricard has completed the sale of its international wine portfolio, including brands like Jacob's Creek, to Accolade Wines owner Australian Wine Holdco, it said on Wednesday.

Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade. Accolade shareholders received $7.03 per share in cash, and the company will no longer be listed on the Nasdaq.

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, and virtual primary care company in the market. The combined organization now serves over 20 million Members and more than 1,700 employer and health plan clients as the One Place for Health and Care....

SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, certified voting results for the Special Meeting will be provided in a Form 8-K filed with the U.S. Securities and Exchange Commission.

Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions SEATTLE , March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) has partnered with Oshi Health , a leading virtual clinic specializing in gastrointestinal (GI) conditions that delivers convenient, accessible, whole-person care through a collaborative, multidisciplinary a...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Accolade, Inc. (NASDAQ: ACCD) to Transcarent for $7.03 per share in cash is fair to Accolade shareholders. Halper Sadeh encourages Accolade shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh...